2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Urticaria Chronic: new trials by email Literature Review of Urticaria Chronic trials Research Report on Urticaria Chronic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1% Fexofenadine Hydrochloride Topical Lotion 1% (OP2101) - Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 1 | Completed | OrchestratePharma GmbH | 12 | 2022-04-01 | 2023-03-29 |
| Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UB-221 as an Add-on Therapy in CSU Patients UB-221 - Urticaria Chronic | Phase 1 | Completed | United BioPharma | 15 | 2019-04-09 | 2022-05-13 |
Chronic Urticaria (2) · Dermatitis (1) · Dermatitis, Atopic (1) · Eczema (1) · Exanthema (1) · Pruritus (1) · Psoriasis (1) · Urticaria (1)
Chronic Disease (2) · Disease Attributes (2) · Hypersensitivity (2) · Hypersensitivity, Immediate (2) · Immune System Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Skin Diseases (2) · Skin Diseases, Vascular (2) · Skin and Connective Tissue Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Signs and Symptoms (1) · Skin Diseases, Eczematous (1) · Skin Diseases, Genetic (1)
OrchestratePharma GmbH (1) · United BioPharma (1)
Bangladesh (1) · Taiwan (1)